Analytical validation of novel cardiac biomarkers used in clinical trials

American Heart Journal

Volumn 169, Issue 5, 2015, Pages 674-683

  Wu, Alan H B ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C PEPTIDE; C REACTIVE PROTEIN; COPEPTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; MAJOR BASIC PROTEIN; NATRIURETIC FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROTEIN; TROPONIN; TROPONIN T; VASOPRESSIN;

ANALYTICAL ERROR; ARTICLE; BIOCHEMISTRY; BLOOD COLLECTION TUBE; BLOOD SAMPLING; CARDIOVASCULAR SYSTEM EXAMINATION; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CLINICAL LABORATORY; CLINICAL TRIAL (TOPIC); CORRELATION ANALYSIS; DISEASE MARKER; FOOD AND DRUG ADMINISTRATION; HOSPITAL DISCHARGE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPOPROTEIN BLOOD LEVEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTOCOL COMPLIANCE; REFERENCE VALUE; VALIDATION STUDY; VASOPRESSIN BLOOD LEVEL; BLOOD; GOVERNMENT REGULATION; STANDARDS; UNITED STATES;

BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; GOVERNMENT REGULATION; HUMANS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VALIDATION STUDIES AS TOPIC;

EID: 84929296469     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2015.01.016     Document Type: Article

References (47)

1. R.S. Vasa Biomarkers of cardiovascular disease. Molecular basis and practical considerations Circulation 113 2006 2335 2362
2. E.O. Weinberg, M. Shimpo, and G.W. De Keulenaer Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction Circulation 106 2002 2961 2966
3. S. Sanada, D. Hakuno, and L.J. Higgins Il-33 and ST2 comprise a critically biomechanically induced and cardioprotective signaling system J Clin Invest 117 2007 1538 1549
4. D.W. Morrow, and E. Braunwald Future of biomarkers in acute coronary syndromes: moving towards a multimarker strategy Circulation 108 2003 250 252
5. T.W. Jacobs, A.M. Gown, and H. Yaziji Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system J Clin Oncol 17 1999 1983 1987
6. J.G. Lainchbury, R.W. Troughton, and K.M. Strangman N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED Trial JACC 55 2010 53 60
7. K. Starnberg, A. Jeppsson, and B. Lindahl Revision of the troponin T release mechanism from damaged human myocardium Clin Chem 60 2014 1098 1104
8. D.L. Dries, B. Ky, and A.H. Wu Simultaneous assessment of unprocessed proBNP1-108 in addition to processed BNP32 improves identification of high-risk ambulatory patients with heart failure Circ Heart Fail 3 2010 220 227
9. J. Lund, S. Wittfooth, and Q.P. Qin Free vs. total pregnancy-associated plasma protein A (PAPP-A) as a predictor of 1-year outcome in patients presenting with non-ST-elevation acute coronary syndrome Clin Chem 56 2010 1158 1165
10. A.S. Jaffe, and J.E. Van Eyke Degradation of cardiac troponins D.A. Morrow, Implications for clinical practice 2006 Cardiovascular Biomarkers, Human Totowa, NJ 261 274
11. K.N. Luckenbill, A.S. Jaffe, and J. Mair Cross-reactivity of BNP, NT-proBNP and proBNP in commercial NT-proBNP assays: a substudy from the IFCC Committee for Standardization of Markers of Cardiac Damage Clin Chem 54 2008 619 621
12. R.M. Dorizzi, M. Caputo, and A. Ferrari Comparison of serum and heparin-polasma samples in different generations of dimension tropnin I assay Clin Chem 49 2003 2294 2296
13. J. Shih, S.A. Datwyler, and S.C. Hsu Effect of collection tube type and preanalytical handling on myeloperoxidase concentrations Clin Chem 54 2008 1076 1079
14. R. Tertti, S. Wittfooth, and P. Porela Intravenous administration of low molecular weight and unfractionated heparin elicits a rapidincrease in serum pregnancy-associated plasma protein A Clin Chem 55 2009 1214 1217
15. A.M. Halldorsdottir, J. Stoker, and R. Porce-Sorbet Soluble CD40 ligand measurement inaccurcies attributeable to specimen type, processing time, and ELISA method Clin Chem 51 2005 1054 1057
16. Q. Lu, B.V. Hofferbert, and G. Koo In vitro shear stress-induced platelet activation: sensitivity of human and bovine blood Artif Organs 37 2013 894 903
17. P. Meybohm, K. Zacharowski, and C.F. Weber Point-of-care coagulation management in intensive care medicine Crit Care 17 2013 218 227
18. T. Mueller, A. Gegenhuber, and B. Dieplinger Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples Clin Chem Lab Med 42 2004 942 944
19. A. Belenky, A. Smith, and B. Zhang The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma Clin Chim Acta 340 2004 163 172
20. A.H.B. Wu, Y.J. Feng, and R. Moore Characterization of cardiac troponin subunit release into serum following acute myocardial infarction, and comparison of assays for troponin T and I Clin Chem 44 1998 1198 1208
21. F.S. Apple, M.M. Murakami, and R.H. Christenson Analytical performance of the i-STAT cardiac troponin I assay Clin Chim Acta 345 2004 123 127
22. A.H.B. Wu, E. Shea, and Q.T. Lu Short- and long-term cardiac troponin I analyte stability in plasma and serum from healthy volunteers by use of an ultrasensitive, single-molecule counting assay Clin Chem 55 2009 2057 2059
23. S.K. Agarwal, C.L. Avery, and C.M. Ballantyne Sources of variability in measurements of cardiac troponin T in a community-base sample: the Atherosclerosis Risk in Communitites Study Clin Chem 57 2011 891 897
24. F.S. Apple, and P.O. Collinson Analytical characteristics of high-sensitivity cardiac troponin assays Clin Chem 58 2012 54 61
25. A.E. Kitabchi Proinsulin and C-peptide: a review Metabolism 26 1977 547 587
26. N.G. Morgenthaler, J. Struck, and C. Alonso Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin Clin Chem 52 2006 112 119
27. N.G. Morgenthaler, J. Struck, and C. Alonso Measurement of midregionalproadrenomedeullin in plasma with an immunoluminometric assay Clin Chem 51 2005 1823 1829
28. N.G. Morgenthal, J. Struck, and B. Thomas Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasam Clin Chem 50 2004 234 236
29. P.O. Collinson, O. Clifford-Mobley, and D. Gaze Assay imprecision and 99th percentile reference value of a high-sensitivity cardiac troponin I assay Clin Chem 55 2009 1433 1434
30. A. Clerico, M. Zaninotto, and C. Prontera State of the art of BNP and NT-proBNP immunoassays: the CardioOrmoCheck study Clin Chim Acta 414 2012 112 119
31. J.S. Krouwer, J.R. Astles, and W.G. Cooper Estimation of total analytical error for clinical laboratory methods Guideline EP21-A 2003 Clinical and Laboratory Standard Institute Wayne, PA
32. C. Fraser Biologica Variation From principles to practice 2001 AACC Press Washington DC
33. A.H.B. Wu, A. Lu, and J. Todd Short- and long-term biological variation in cardiac troponin I with a high-sensitivity assay: implications for clinical practice Clin Chem 55 2009 52 58
34. T. Keller, T. Zeller, and F. Ojeda Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction JAMA 306 2011 2684 2693
35. C. Ricos, V. Alvarez, and F. Cava Current databases on biological variation: pros, cons and progress Scand J Clin Lab Invest 59 1999 491 500
36. C.G. Fraser Test result variation and the quality of evidence-based clinical guidelines Clin Chim Acta 346 2004 19 24
37. J.A. De Lemos, M.H. Drazner, and T. Omland Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general popluation JAMA 304 2010 2503 2515
38. P.O. Collinson, Y.M. Heung, and D. Gaze Influence of population selection on the 99th percentile reference value for cardiac torponin assays Clin Chem 58 2012 219 225
39. Clinical and Laboratory Standards Institute Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline CLSI document C28-A3 3rd ed. 2008 Clinical and Laboratory Standards Institute Wayne, PA
40. M.O. Gore, S.L. Seliger, and C.R. de Filippi Age- and sex-dependent upper reference limits for the high-sensitivity troponin T assay J Am Coll Cardiol 63 2014 1441 1448
41. W.G. Miller, G.L. Myers, and M.L. Gantzer Roadmap for harmonization of clinical laboratory measurement procedures Clin Chem 57 2011 1108 1117
42. F.S. Apple Counterpoint: standardization of cardiac troponin I assays will not occur in my lifetime Clin Chem 58 2012 169 171
43. F.S. Apple, J. Hollander, and A.H.B. Wu Improving the 519(k) process for cardiac troponin assays: in search for common ground Clin Chem 60 2014 1273 1275
44. P.M. Bossuyt, J.B. Reistma, and D. Bruns The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration Clin Chem 49 2003 7 18
45. M.S. Sabatine, E. Liu, and D.A. Morrow Metabolimic identification of novel biomarkers of myocardial ischemia Circulation 112 2005 3868 3875
46. J. Kim, N. Ghazemazdeh, and D.J. Eapen Gene expression profiles associated with acute myocardial infarction and risk of cardiovascular death Genome Med 6 2014 [in press]
47. M. Fan, S. Dandona, and R. McPherson Two chromosome 9p21 haplotype blocks distinguish between coronary artery disease and myocardial infarction risk Circ Cardiovasc Genet 6 2013 372 380